ID

14565

Descripción

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01031368

Link

https://clinicaltrials.gov/show/NCT01031368

Palabras clave

Versiones (1)
  1. 21/4/16 21/4/16 -
Subido en

21 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01031368

Inglés

Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01031368

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
cohort a: diagnosis of aml by world health organization (who) criteria, either relapsed or refractory; acute promyelocytic leukemia [acute promyelocytic leukemia with t(15;17)(q22;q12) and variants] will be eligible only after failure of a regimen containing arsenic trioxide; patients in this cohort must have had an initial remission duration of < 1 year and cannot have received any prior salvage chemotherapy
Descripción

aml

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023467
cohort b: untreated aml patients, excluding those with favorable cytogenetic or molecular abnormalities per the european leukemianet recommendations
Descripción

untreated aml

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0332155
cohort c: untreated aml patients, including those with favorable cytogenetic or molecular abnormalities per the european leukemianet recommendations
Descripción

untreated aml

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0332155
UMLS CUI [1,3]
C0010802
the first three patients enrolled in cohorts a and b must be less than 60 years old; thereafter, patients aged >= 18 and =< 70 are eligible
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
the first three patients enrolled in cohorts a and b must have an eastern cooperative oncology group (ecog) performance status of 0 -1; thereafter, ecog performance status of 0-2 is required
Descripción

eastern cooperative oncology group (ecog) performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
serum creatinine =< 1.0 mg/dl; if serum creatinine > 1.0 mg/dl, then the estimated glomerular filtration rate (gfr) must be > 60 ml/min/1.73 m^2 as calculated by the modification of diet in renal disease equation where predicted gfr (ml/min/1.73 m^2) = 186 x (serum creatinine)^-1.154 x (age in years)^-0.203 x (0.742 if patient is female) x (1.212 if patient is black)
Descripción

serum creatinine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
serum total bilirubin =< 1.5 x upper limit of normal (uln) unless elevation is thought to be due to gilbert's syndrome, hemolysis, or hepatic infiltration by the hematologic malignancy
Descripción

serum total bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
aspartate aminotransferase (ast)/alanine aminotransferase (alt) =< 2.5 x uln, unless elevation is thought to be due to hepatic infiltration by the hematologic malignancy
Descripción

aspartate aminotransferase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
alkaline phosphatase =< 2.5 x uln
Descripción

alkaline phosphatase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1561546
capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
female patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to enrollment
Descripción

negative serum pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0430061
male and female patients must be willing to use an effective contraceptive method during the study and for a minimum of 90 days after study treatment
Descripción

Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
allogeneic transplant recipients
Descripción

allogeneic transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149615
cytotoxic chemotherapy, radiation therapy, immunosuppressants, or cytokine treatment within 4 weeks prior to study entry or persistent clinical evidence of toxicity.
Descripción

chemotherapy, radiation therapy, immunosuppressants, or cytokine treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0021081
UMLS CUI [1,4]
C0199974
have any other severe concurrent disease, or have a history of serious organ dysfunction or disease involving the heart, kidney, liver (including symptomatic hepatitis, veno-occlusive disease), or other organ system dysfunction
Descripción

concurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
patients with a systemic fungal, bacterial, viral, or other infection not controlled (defined as exhibiting ongoing signs/symptoms related to the infection and without improvement, despite appropriate antibiotics or other treatment)
Descripción

systemic infection and inflammation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3646020
pregnant or lactating patients
Descripción

pregnant or lactating

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0549206
UMLS CUI [1,2]
C0006147
any significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow up, or interpretation of study results
Descripción

compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0009488
Volver a la parte superior de la página

Similar models

Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01031368

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
aml
Item
cohort a: diagnosis of aml by world health organization (who) criteria, either relapsed or refractory; acute promyelocytic leukemia [acute promyelocytic leukemia with t(15;17)(q22;q12) and variants] will be eligible only after failure of a regimen containing arsenic trioxide; patients in this cohort must have had an initial remission duration of < 1 year and cannot have received any prior salvage chemotherapy
boolean
C0023467 (UMLS CUI [1])
untreated aml
Item
cohort b: untreated aml patients, excluding those with favorable cytogenetic or molecular abnormalities per the european leukemianet recommendations
boolean
C0023467 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
untreated aml
Item
cohort c: untreated aml patients, including those with favorable cytogenetic or molecular abnormalities per the european leukemianet recommendations
boolean
C0023467 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0010802 (UMLS CUI [1,3])
age
Item
the first three patients enrolled in cohorts a and b must be less than 60 years old; thereafter, patients aged >= 18 and =< 70 are eligible
boolean
C0001779 (UMLS CUI [1])
eastern cooperative oncology group (ecog) performance status
Item
the first three patients enrolled in cohorts a and b must have an eastern cooperative oncology group (ecog) performance status of 0 -1; thereafter, ecog performance status of 0-2 is required
boolean
C1520224 (UMLS CUI [1])
serum creatinine
Item
serum creatinine =< 1.0 mg/dl; if serum creatinine > 1.0 mg/dl, then the estimated glomerular filtration rate (gfr) must be > 60 ml/min/1.73 m^2 as calculated by the modification of diet in renal disease equation where predicted gfr (ml/min/1.73 m^2) = 186 x (serum creatinine)^-1.154 x (age in years)^-0.203 x (0.742 if patient is female) x (1.212 if patient is black)
boolean
C0201976 (UMLS CUI [1])
serum total bilirubin
Item
serum total bilirubin =< 1.5 x upper limit of normal (uln) unless elevation is thought to be due to gilbert's syndrome, hemolysis, or hepatic infiltration by the hematologic malignancy
boolean
C1278039 (UMLS CUI [1])
aspartate aminotransferase
Item
aspartate aminotransferase (ast)/alanine aminotransferase (alt) =< 2.5 x uln, unless elevation is thought to be due to hepatic infiltration by the hematologic malignancy
boolean
C0201899 (UMLS CUI [1])
alkaline phosphatase
Item
alkaline phosphatase =< 2.5 x uln
boolean
C1561546 (UMLS CUI [1])
informed consent
Item
capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent
boolean
C0021430 (UMLS CUI [1])
negative serum pregnancy test
Item
female patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to enrollment
boolean
C0430061 (UMLS CUI [1])
Contraceptive methods
Item
male and female patients must be willing to use an effective contraceptive method during the study and for a minimum of 90 days after study treatment
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
allogeneic transplant
Item
allogeneic transplant recipients
boolean
C0149615 (UMLS CUI [1])
chemotherapy, radiation therapy, immunosuppressants, or cytokine treatment
Item
cytotoxic chemotherapy, radiation therapy, immunosuppressants, or cytokine treatment within 4 weeks prior to study entry or persistent clinical evidence of toxicity.
boolean
C0392920 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0021081 (UMLS CUI [1,3])
C0199974 (UMLS CUI [1,4])
concurrent disease
Item
have any other severe concurrent disease, or have a history of serious organ dysfunction or disease involving the heart, kidney, liver (including symptomatic hepatitis, veno-occlusive disease), or other organ system dysfunction
boolean
C0009488 (UMLS CUI [1])
systemic infection and inflammation
Item
patients with a systemic fungal, bacterial, viral, or other infection not controlled (defined as exhibiting ongoing signs/symptoms related to the infection and without improvement, despite appropriate antibiotics or other treatment)
boolean
C3646020 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating patients
boolean
C0549206 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
compliance
Item
any significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow up, or interpretation of study results
boolean
C0525058 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial